Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study

BACKGROUND: The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial is aimed at addressing the urgent need to find effective treatments for patients hospitalised with suspected or confirmed COVID-19. The trial has had many successes, including discovering that dexamethasone is effective at re...

Descripción completa

Detalles Bibliográficos
Autores principales: Sirkis, Tamir, Jones, Benjamin, Bowden, Jack
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356442/
https://www.ncbi.nlm.nih.gov/pubmed/35933340
http://dx.doi.org/10.1186/s12874-022-01691-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356442/
https://www.ncbi.nlm.nih.gov/pubmed/35933340
http://dx.doi.org/10.1186/s12874-022-01691-w

Ejemplares similares